Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders
Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Co-Chairs

Dr. Bunn
Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor and Director
University of Colorado Cancer Center
Denver, CO
Executive Director
International Association for the Study of Lung Cancer
(IASLC)

Dr. Bunn
Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Dr. Bunn
Corey J. Langer, MD
Director of Thoracic Oncology
University of Pennsylvania
Philadelphia, PA
Vice Chair of the Radiation Therapy Oncology Group
(RTOG)


Other Expert Faculty

Dr. Albain
Kathy S. Albain, M.D.

Professor of Medicine
Loyola University Chicago Stritch School of Medicine
Director, Thoracic Oncology Program
Director, Breast Clinical Research Program
Cardinal Bernardin Cancer Center
Maywood, IL

Gerold Bepler, MD, PhD
Professor of Medicine and Oncology
Division Chief and Program Leader
Thoracic Oncology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL

Dr. Bonomi
Philip Bonomi, MD

Alice Pirie Wirtz Professor of Medical Oncology
Director, Division of Hematology-Oncology
Rush University Medical Center
Chicago, IL

David P. Carbone, MD, PhD
Harold L. Moses Chair in Cancer Research
Ingram Professor of Cancer Research
Director of Specialized Program of Research Excellence in Lung Cancer
Ingram-Vanderbilt Cancer Center
Nashville, TN

 


Walter J. Curran, MD, FACR
Professor and Chair
Department of Radiation Oncology
Emory School of Medicine Chief Medical Officer
Winship Cancer Institute
Atlanta, GA
Chairman, Radiation Therapy Oncology Group
(RTOG)

Martin J. Edelman, MD
Professor of Medicine
Director of Medical Thoracic Oncology
University of Maryland Greenebaum Cancer Center
Baltimore, MD

David R. Gandara, MD
Professor of Medicine Director, Thoracic Oncology Program Associate Director for Clinical Research,
UC Davis Cancer Center
Sacramento, CA
Chair, Lung Committee, Southwestern Oncology Group
(SWOG)

Richard J. Gralla, MD
Vice President, Cancer Services
Chief, Division of Hematology & Oncology
Monter Cancer Center
North Shore-LIJ Health System
Lake Success, NY

John V. Heymach, MD, PhD
Assistant Professor of Thoracic Head/Neck Medical Oncology
Assistant Professor of Cancer Biology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Fred R. Hirsch, MD
Professor of Medicine and Pathology
University of Colorado Cancer Center
Denver, CO

David Jablons, MD
Section Chief, General Thoracic Surgery
Professor of Surgery
Division of Cardiothoracic Surgery
University of California, San Francisco
San Francisco, CA

Dr. Kim
Edward S. Kim, MD

Assistant Professor
Department of Thoracic/Head & Neck Cancer
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Mark G. Kris, MD
Chief, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan-Kettering Cancer Center
New York, NY

Primo N. Lara, Jr., MD
Professor of Medicine
Director, Clinical Trials Support Unit
UC Davis Cancer Center
Sacramento, CA

Thomas J. Lynch, MD
Chief, Division of Hematology and Oncology
Director, Center for Thoracic Cancer
Massachusetts General Hospital
Cancer Center
Boston, MA

Vincent A. Miller , MD
Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, NY

Gordon Mills, MD, PhD
Chairman, Department of Molecular Therapeutics Professor of Medicine
University of Texas
M. D. Anderson Cancer Center
Houston, TX

John D. Minna, MD
Max L.Thomas Distinguished Chair in Molecular Pulmonary Oncology
Sarah M. and Charles E. Seay Distinguished Chair in Cancer Research
Professor, Internal Medicine
Graduate School of Biomedical Sciences
UT Southwestern Medical Center
Dallas, TX

Jeffrey N. Myers, MD, PhD
Professor and Deputy Chair for Academic Programs
Director of Research for Head and Neck Surgery
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Joseph R. Nevins, PhD
Barbara Levine University Professor of Cancer Genomics
Duke University
Durham, NC

Dr. Patel
Jyoti D. Patel, MD

Assistant Professor
Division of Hematology/Oncology
Robert H. Lurie Comprehensive
Cancer Center
Northwestern University
Chicago, IL

Dr. Salgia
Ravi Salgia, MD, PhD

Associate Professor of Medicine
Director, Thoracic Oncology Research Program
University of Chicago Medical Center
Chicago, IL

Alan B. Sandler, MD
Associate Professor of Cancer Research,
Lung Cancer
Ingram-Vanderbilt Cancer Center
Nashville, TN

Joan H. Schiller, MD
Professor & Division Chief,
Hematology-Oncology
Deputy Director, Harold C. Simmons Cancer Center
Andrea L. Simons Distinguished Chair in Cancer Research
UT Southwestern Medical Center
Dallas, TX
Chair, Lung Committee, Eastern Cooperative Oncology Group (ECOG)

David Sidransky, MD
Professor of Oncology,
Pathology and Cellular and Molecular Medicine
Director, Head and Neck Cancer Research
Johns Hopkins Medical Institutions
Baltimore, MD

George R. Simon, MD, FACP, FCCP
Associate Member
Department of Thoracic Oncology and Experimental Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL

Everett E. Vokes, MD
Director, Section of Hematology/Oncology
Deputy Director, Cancer Research Center
John E. Ultmann Professor of Medicine
Radiation and Cellular Oncology
The University of Chicago Medical Center
Chair, Lung Committee, Cancer and Leukemia Group B
(CALGB)

Ralph Zinner, MD
Associate Professor of Medicine
University of Texas
M. D. Anderson Cancer Center
Houston, TX

Tell a friend about this symposium Print the Agenda Email the Agenda

September 20-21, 2008 · The W Chicago City Center · Chicago, IL

A completely new concept in medical education for thoracic malignancies, developed to help clinicians improve their selection of the most appropriate targeted therapeutics and chemotherapeutics, and also help them to identify certain patient sub-populations of thoracic malignancies who may best respond to specific drug therapies

CO-CHAIRS

Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor and Director
University of Colorado Cancer Center
Denver, CO
Executive Director
International Association for the Study of Lung Cancer
(IASLC)

Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas, M. D. Anderson Cancer Center
Houston, TX

Corey J. Langer, MD
Director of Thoracic Oncology
University of Pennsylvania
Philadelphia, PA

Vice Chair of the Radiation Therapy Oncology Group
(RTOG)



ORGANIZING COMMITTEE


Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor and Director
University of Colorado Cancer Center
Denver, CO

Executive Director,
International Association for the Study of Lung Cancer
(IASLC)

Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas, M. D. Anderson Cancer Center
Houston, TX

David Jablons, MD
Section Chief, General Thoracic Surgery
Professor of Surgery
Division of Cardiothoracic Surgery
University of California, San Francisco
San Francisco, CA

Corey J. Langer, MD
Director of Thoracic Oncology
University of Pennsylvania
Philadelphia, PA Vice Chair,
Radiation Therapy Oncology Group
(RTOG)

Joan H. Schiller, MD
Professor & Division Chief,
Hematology/Oncology
Deputy Director, Harold C. Simmons Comprehensive Cancer Center
Andrea L. Simmons Distinguished Chair in Cancer Research
UT Southwestern Medical Center

Dallas, TX
Chair, Lung Committee, Eastern Cooperative Oncology Group
(ECOG)

Everett E. Vokes, MD
Director, Section of Hematology/Oncology
Deputy Director, Cancer Research Center
John E. Ultmann Professor of Medicine
Radiation and Cellular Oncology
The University of Chicago Medical Center
Chair, Lung Committee, Cancer and Leukemia Group B
(CALGB)

   
Educational Statement of Need
Overview
Disclosure
Target Audience
Learning Objectives
CME Credit Information
Methods of Participation
Agenda
Faculty
Educational Grant Sponsorship Opportunities
Hotel: Chicago W
Registration
   

Disclosure Back to Top
DISCLOSURE STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) standards for Commercial Support, educational activities sponsored by the Oncology Learning Center (OLC) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, content and planning committee members participating in an OLC-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an OLC educational activity.

FACULTY/STAFF DISCLOSURE
Coming Soon.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The Oncology Learning Center (OLC) does not recommend the use of any agent outside of the FDA labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official FDA prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Educational Grants

Sincere appreciation is extended to the following companies for their generous support of this educational meeting: Genentech BioOncology, OSI Oncology, Lilly, Bristol-Myers Squibb, ImClone Systems Incorporated, sanofi-aventis, Biogen Idec, Poniard Pharmaceuticals, OSI Pharmaceuticals




























© 2012 Biomedical Learning Institute
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.